Biology

Wed, 03/01/2018 - 11:30
Flanders, Belgium, 3rd January 2018 / Sciad Newswire / Bruges, Belgium will host the third edition of 
Thu, 14/12/2017 - 07:30
London, UK, 14th December 2017 / Sciad Newswire / ‘Trends and truth in life science investment’ is the latest annual report, published by
Wed, 13/12/2017 - 10:00
13th December 2017 / Sciad Newswire / Amyndas Pharmaceuticals, which is committed to developing innovative therapeutics for
Mon, 16/10/2017 - 07:30
London, UK, 16th October 2017 / Sciad Newswire / BioMoti, Pharmidex and
Thu, 28/09/2017 - 08:30
London, UK, 28th September 2017 / Sciad Newswire / The US approval of Novartis's  Kymriah for childhood leukaemia opens a dramatic new era of cancer therapy deplo
Mon, 18/09/2017 - 07:30
Cambridge, UK, 18th September 2017 / Sciad Newswire / Cypralis, a life sciences company focused on the discovery of therape
Wed, 12/07/2017 - 12:23
London, UK, 12th July 2017 / Sciad Newswire / SynbiCITE and Rainbow Seed Fund co
Thu, 29/06/2017 - 07:30
Australian immuno-oncology company Minomic International Ltd is proceeding to the second stage of its pioneering MILGa clinical trial of MiltuximabTM, a chimeric version of Minomic’s MIL-38 anti-Glypican1 antibody conjugated to the radioactive isotope 67Gallium.
Thu, 22/06/2017 - 07:00
First acquisition made by Invent Farma / neuraxpharm following the creation of the Group by funds advised by Apax Partners in August 2016

Pages